77,138 research outputs found
Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis
Purpose
To systematically review and evaluate the methodological quality of studies using radiomics for diagnostic and predictive purposes in patients with intracranial meningioma. To perform a meta-analysis of machine learning studies for the prediction of intracranial meningioma grading from pre-operative brain MRI.
Methods
Articles published from the year 2000 on radiomics and machine learning applications in brain imaging of meningioma patients were included. Their methodological quality was assessed by three readers with the radiomics quality score, using the intra-class correlation coefficient (ICC) to evaluate inter-reader reproducibility. A meta-analysis of machine learning studies for the preoperative evaluation of meningioma grading was performed and their risk of bias was assessed with the Quality Assessment of Diagnostic Accuracy Studies tool.
Results
In all, 23 studies were included in the systematic review, 8 of which were suitable for the meta-analysis. Total (possible range, −8 to 36) and percentage radiomics quality scores were respectively 6.96 ± 4.86 and 19 ± 13% with a moderate to good inter-reader reproducibility (ICC = 0.75, 95% confidence intervals, 95%CI = 0.54–0.88). The meta-analysis showed an overall AUC of 0.88 (95%CI = 0.84–0.93) with a standard error of 0.02.
Conclusions
Machine learning and radiomics have been proposed for multiple applications in the imaging of meningiomas, with promising results for preoperative lesion grading. However, future studies with adequate standardization and higher methodological quality are required prior to their introduction in clinical practice
Radiomics risk modelling using machine learning algorithms for personalised radiation oncology
One major objective in radiation oncology is the personalisation of cancer treatment. The implementation of this concept requires the identification of biomarkers, which precisely predict therapy outcome. Besides molecular characterisation of tumours, a new approach known as radiomics aims to characterise tumours using imaging data. In the context of the presented thesis, radiomics was established at OncoRay to improve the performance of imaging-based risk models. Two software-based frameworks were developed for image feature computation and risk model construction. A novel data-driven approach for the correction of intensity non-uniformity in magnetic resonance imaging data was evolved to improve image quality prior to feature computation. Further, different feature selection methods and machine learning algorithms for time-to-event survival data were evaluated to identify suitable algorithms for radiomics risk modelling. An improved model performance could be demonstrated using computed tomography data, which were acquired during the course of treatment. Subsequently tumour sub-volumes were analysed and it was shown that the tumour rim contains the most relevant prognostic information compared to the corresponding core. The incorporation of such spatial diversity information is a promising way to improve the performance of risk models.:1. Introduction
2. Theoretical background
2.1. Basic physical principles of image modalities
2.1.1. Computed tomography
2.1.2. Magnetic resonance imaging
2.2. Basic principles of survival analyses
2.2.1. Semi-parametric survival models
2.2.2. Full-parametric survival models
2.3. Radiomics risk modelling
2.3.1. Feature computation framework
2.3.2. Risk modelling framework
2.4. Performance assessments
2.5. Feature selection methods and machine learning algorithms
2.5.1. Feature selection methods
2.5.2. Machine learning algorithms
3. A physical correction model for automatic correction of intensity non-uniformity
in magnetic resonance imaging
3.1. Intensity non-uniformity correction methods
3.2. Physical correction model
3.2.1. Correction strategy and model definition
3.2.2. Model parameter constraints
3.3. Experiments
3.3.1. Phantom and simulated brain data set
3.3.2. Clinical brain data set
3.3.3. Abdominal data set
3.4. Summary and discussion
4. Comparison of feature selection methods and machine learning algorithms
for radiomics time-to-event survival models
4.1. Motivation
4.2. Patient cohort and experimental design
4.2.1. Characteristics of patient cohort
4.2.2. Experimental design
4.3. Results of feature selection methods and machine learning algorithms evaluation
4.4. Summary and discussion
5. Characterisation of tumour phenotype using computed tomography imaging
during treatment
5.1. Motivation
5.2. Patient cohort and experimental design
5.2.1. Characteristics of patient cohort
5.2.2. Experimental design
5.3. Results of computed tomography imaging during treatment
5.4. Summary and discussion
6. Tumour phenotype characterisation using tumour sub-volumes
6.1. Motivation
6.2. Patient cohort and experimental design
6.2.1. Characteristics of patient cohorts
6.2.2. Experimental design
6.3. Results of tumour sub-volumes evaluation
6.4. Summary and discussion
7. Summary and further perspectives
8. Zusammenfassun
Recommended from our members
A High-Performance Inversion Framework for Brain Tumor Growth Models in Personalized Medicine
The precise characterization of aggressive brain tumors remains a challenging problem due to their highly heterogeneous radiographic and molecular presentation. The integration of mathematical models with clini- cal imaging data holds an enormous promise of developing robust predictive and explainable models that quantify cancer growth with the potential to as- sist in diagnosis and treatment. In general, such models are parameterized by many unknown parameters and their estimation can be formally posed as an inverse problem. However, this calibration problem is a formidable task for aggressive brain tumors due to the absence of longitudinal data, resulting in a strongly ill-posed inverse problem. This is further exacerbated by the inherent non-linearity in tumor growth models. Overcoming these difficulties involves the introduction of sophisticated regularization strategies along with compu- tationally efficient algorithms and software. Towards this end, we introduce a fully-automatic inversion framework which provides an entirely new capa- bility to analyze complex brain tumors from a single pretreatment magnetic resonance imaging (MRI) scan. Our framework employs fast algorithms and optimized implementations which exploit distributed-memory parallelism and GPU acceleration to enable reasonable solution times – an important factor for clinical applications. We validate our solver on clinical data and demonstrate its utility in characterizing important biophysics of brain cancer along with its ability to complement other radiographic information in downstream machine learning tasks
Deep Learning versus Classical Regression for Brain Tumor Patient Survival Prediction
Deep learning for regression tasks on medical imaging data has shown
promising results. However, compared to other approaches, their power is
strongly linked to the dataset size. In this study, we evaluate
3D-convolutional neural networks (CNNs) and classical regression methods with
hand-crafted features for survival time regression of patients with high grade
brain tumors. The tested CNNs for regression showed promising but unstable
results. The best performing deep learning approach reached an accuracy of
51.5% on held-out samples of the training set. All tested deep learning
experiments were outperformed by a Support Vector Classifier (SVC) using 30
radiomic features. The investigated features included intensity, shape,
location and deep features. The submitted method to the BraTS 2018 survival
prediction challenge is an ensemble of SVCs, which reached a cross-validated
accuracy of 72.2% on the BraTS 2018 training set, 57.1% on the validation set,
and 42.9% on the testing set. The results suggest that more training data is
necessary for a stable performance of a CNN model for direct regression from
magnetic resonance images, and that non-imaging clinical patient information is
crucial along with imaging information.Comment: Contribution to The International Multimodal Brain Tumor Segmentation
(BraTS) Challenge 2018, survival prediction tas
- …